Condition
Spider Veins
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 4 (1)
Trial Status
Completed4
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07073742Phase 2Not Yet Recruiting
CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb Telangiectasias
NCT02754479Not ApplicableCompletedPrimary
A Clinical Evaluation of the Treatment of Spider Veins on the Ankles
NCT04148950Not ApplicableCompleted
Effects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous Disease
NCT02286804Not ApplicableCompleted
Ultherapy for the Treatment of Spider Veins on the Legs
NCT01362192Phase 4Completed
Treatment of Lower Extremity Spider Veins With Excel V
Showing all 5 trials